Hematology/Oncology Associates of Central New York — East Syracuse, New York

Hematology/Oncology Associates of Central New York is a clinical research site located in East Syracuse, New York, United States.

Crixeo Clinical Trials Trust Score: 21/100 (FAILING). This profile has not yet been claimed by the site owner.

Hematology/Oncology Associates of Central New York has participated in 18 clinical trials with 8 currently active.

Therapeutic areas: Prostatic Neoplasms, Chronic Lymphocytic Leukemia (CLL), Lymphoma.

Sponsors: Millennium Pharmaceuticals, Inc., Pharmacyclics LLC., Hoffmann-La Roche.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in East Syracuse

Browse all research sites in New York · View every site in East Syracuse

Sponsor Feasibility Report

Trust Score: 21/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Hematology/Oncology Associates of Central New York?

Hematology/Oncology Associates of Central New York has a Crixeo Trust Score of 21/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Hematology/Oncology Associates of Central New York conducted?

Hematology/Oncology Associates of Central New York has 18 clinical trials on record, with 8 currently active. Their work covers Prostatic Neoplasms, Chronic Lymphocytic Leukemia (CLL), Lymphoma.

Is Hematology/Oncology Associates of Central New York accredited by Crixeo Clinical Trials?

Hematology/Oncology Associates of Central New York has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Hematology/Oncology Associates of Central New York?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.